Silvia Bio is a University of Sheffield biotechnology spinout accelerating biomanufacturing by identifying bottlenecks in mammalian cells and delivering precision media solutions that improve the predictability of bioprocesses. Its proprietary platform combines rapid cell profiling with bioreactor-compatible media additives designed to increase product titre and critical quality attributes. The company works across biologics manufacturing, including antibodies, vaccines and gene therapies.
Silvia Bio: Venture Capital Funding History
Silvia Bio
Silvia Bio
- Life Sciences
- Sheffield, United Kingdom
- £3m
- silviabio.com
- Update Information
More venture news
- 15 Oct 2026

MedcotecMedcotec announces its £2.4m seed round from VCs to help pharma manufacturers transfer powders with single-use valves
SeedLife Sciences - 15 Oct 2026

Silvia BioSilvia Bio raises a £3m seed round led by Northern Gritstone to improve complex biopharmaceutical manufacturing
SeedLife Sciences - 13 Oct 2026

Undecimal BioUndecimal Bio lands a £14m seed round led by 4BIO Capital and IQ Capital to unlock targeted delivery of RNA drugs beyond the liver
SeedLife Sciences
